← FDA DRUG APPROVALS

FDA ANDA · ANDA217774

ACITRETIN

Sponsor: ALEMBIC

APPLICATION
ANDA217774
TYPE
ANDA
ORIGINAL APPROVAL
2024-08-05
LATEST ACTION
2024-08-05
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

ACITRETINPrescription
ACITRETIN 25MG · CAPSULE · ORAL
ACITRETINPrescription
ACITRETIN 10MG · CAPSULE · ORAL
ACITRETINPrescription
ACITRETIN 17.5MG · CAPSULE · ORAL

Approval history

2024-08-05UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →